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Abstract: Aim: This paper explores the possible association between antibiotics prescribed in infancy and allergic disor-
ders, mainly eczema and asthma, in childhood. 
Background: No-one fully understands why childhood asthma and eczema have become so common. Some authorities 
suggest that there may be an association between eczema and asthma and antibiotics prescribed in childhood; however, 
others disagree. 
Method/Evaluation: The available literature was reviewed to examine the links between prescribed antibiotics and child-
hood eczema and asthma. 
Findings/Key Issue: Some, but not all, research indicates that antibiotic administration in pregnancy, childbirth or infancy 
may be linked to childhood asthma and eczema, but much uncertainty remains. None of the papers identified stated the 
doses of antibiotics prescribed. In addition, we were unable to locate studies reporting the interactions between antibiotics 
and the developing immune system. 
Conclusion: Health care professionals should be selective when prescribing antibiotics. Further prospective work is 
needed to guide the prescribing of antibiotics in childbirth and infancy. 
Keywords: Allergic disorders, antibiotics, prescribing, adverse drug reactions, evidence based practice. 
  Health care professionals, particularly nurses, are en-
couraged to base their practice decisions on research evi-
dence. However, some commentators suggest that this has 
limitations [1,2]. One limitation of the ‘evidence-based para-
digm’ is the absence or paucity, and, consequently, possible 
bias, of evidence to guide decision-making in some circum-
stances. 
  Ideally, every practice activity would be based on the 
results of randomised, multiple blind, parallel group, placebo 
controlled pragmatic clinical trials of adequate size, 
supported by large cohort studies and service users’ views. 
While these standards are sometimes achieved by those 
investigating the benefits of drugs, there has been no 
comparable investment in research into the adverse side 
effects of drugs. As an example, this paper discusses a 
putative adverse drug reaction of antibiotics: asthma and 
eczema in childhood. 
ALLERGIC DISORDERS IN CHILDHOOD 
  Childhood allergic disorders (mainly asthma, eczema and 
hayfever) are becoming increasingly common and increas-
ingly severe [3,4]. Each year, 12 million people in the UK 
receive treatment for allergic disorders [4]. The prevalence 
of allergic disorders in childhood increased in the latter half 
of the twentieth century: by 1995, 53.9% of UK 12-14 year 
olds (n=27,507) had experienced asthma, hayfever or   
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eczema [5], and 41% of 10 year olds had experienced ec-
zema (n=1456) [6]. 
  Children with even mild wheezing and asthma lose sleep 
due to distressing nocturnal symptoms and 1.5% UK chil-
dren are kept awake at least 1 night each week by wheezing 
[4]. Asthma accounts for 128,604 disability adjusted life 
years in European children aged 0-4, more than any other 
single condition and more than all malignancies in that age 
group [7]. The most severely affected children are frequently 
admitted to hospital, in acute distress, struggling to breathe. 
If urgent preventative action is not taken, asthma deaths 
worldwide will increase by 20% in the next 10 years [8]. 
  Overall, eczema may impose a greater burden on families 
than type 1 diabetes [9]. Skin conditions account for 9,033 
disability adjusted life years in European children aged 0-4 
[7]. Children affected by eczema are unable to sleep or con-
centrate, due to itching: 3% of UK children are kept awake at 
least 1 night each week by eczema [4]. 
  The lives of most sufferers are further restricted by their 
medications. Most children with asthma or eczema receive 
corticosteroids or immunosuppressants, which can have ad-
verse effects, including increased vulnerability to infections, 
and further disturbance of body image. The need for rigorous 
compliance with therapeutic regimens also curtails the 
child’s lifestyle. 
  The burden of atopic disease is falling disproportionately 
on children in developed countries, where the prevalence of 
infectious illness is relatively low [10]. 
  Epidemiological trends, taken with observation studies 
[11], indicate that modern lifestyles may have disrupted the Antibiotics and Allergic Disorders in Childhood  The Open Nursing Journal, 2008, Volume 2    49 
long-standing commensal relationships between humans and 
their microflora: the hygiene hypothesis [12,13]. Children in 
rural Eastern Europe have, to date, largely escaped the ‘al-
lergy epidemic’ [14]. However, the culpable environmental 
components of the modern hygienic environment have not 
been identified. It has been noticed that the increase in aller-
gic disorders co-incided with the introduction of antibiotics. 
In the developed world, the prevalence of allergic disorders 
in childhood may no longer be rising [15, 16], whilst, simul-
taneously, the prescribing of antibiotics in primary care is 
declining [17, 18]. When juxtaposed with biologically plau-
sible mechanisms, these contemporaneous trends circum-
stantially support the association between antibiotics and 
childhood allergy. 
BIOLOGICAL MECHANISMS 
  Causal associations between events and disease may be 
considered with reference to the Bradford Hill criteria [19]: 
strength, consistency, specificity, timeframe and coherence 
of association, the dose-response relationship, biological 
gradient and plausibility, experimental evidence, analogies 
and precedents. There may be a biological basis for the asso-
ciation between antibiotics in childbirth or infancy and aller-
gic disorders in childhood. 
  Allergic disorders are associated with atopy [glossary], 
which occurs when the regulation of the immune system is 
upset and lymphocytes produce IgE antibodies, rather than 
IgG antibodies [glossary]. IgE antibodies trigger release of 
histamine and other inflammatory mediators, which give rise 
to the signs and symptoms of inflammation. The regulation 
of the immune system depends on the balance between the 2 
main types of T helper cells [glossary]: Th1 and Th2. If the 
balance deviates towards the Th2 cells, away from those of 
the Th1 cells, atopy develops. At birth, the Th2 cells pre-
dominate. Normally, environmental factors shift the balance 
of the immune system away from Th2 cells towards Th1 
cells, which prevent the development of allergies. However, 
this change does not occur in children with atopy [20]. This 
is supported by the observation that children experiencing 
fever in early life, which stimulates the Th1 cells, are less 
vulnerable to allergy [21]. 
  In today’s hygienic environment, children, and their im-
mune systems, may be under-exposed to certain micro-
organisms, particularly those that normally inhabit the gut, 
which have been closely associated with the development of 
the immune system of the gastro-intestinal tract during evo-
lutionary history. Previous generations of children encoun-
tered these microbiological ‘old friends’ routinely [22]. At 
birth, the neonate’s gastrointestinal tract is rapidly colonised 
by micro-organisms, mainly from the mother. This colonisa-
tion stimulates the lymphoid tissue lining the gut, which con-
tains at least 60% of the body’s lymphocytes, and drives the 
development of the neonate’s immune system [23, 24]. 
However, the bacteria colonizing the neonatal colon have 
changed since the 1970s and 1980s, with a decrease in gram 
negative organisms, such as E. coli, and an increase in gram 
positive microflora, such as staphylococci. Since the 2 
groups of micro-organisms affect the gut’s immune system 
in different ways, this may have implications for the devel-
opment of allergic disorders [25]. 
 
  Caesarean delivery [26], antibiotics administered to 
women antenatally [27, 28], or in the peripartum period [29] 
or to infants [30-32] may change the initial colonisation and 
the development of the neonatal gut microflora. This could 
affect the regulation of the immune system, predisposing the 
child to develop allergic disorders [33]. Consequently, an 
association between antibiotics, stool flora, the neonatal im-
mune system and the subsequent development of allergy has 
been postulated [34]. However, the impact of prescribed 
medications on the Th1/Th2 cytokine [glossary] balance 
regulating allergy and atopy has not been explored [35, 36]. 
AIM 
  This paper explores the possible association between 
antibiotics in early life and allergic disorders in childhood. 
METHODS AND SEARCHES 
  To identify the available evidence, Medline was searched 
during February 2008, using search terms: antibiotics AND 
childbirth/ labour/ parturition AND allergy/ atopy/ eczema/ 
asthma. Two articles were retrieved, one of which was rele-
vant. The search terms: antibiotics  AND  eczema/ asthma/ 
atopy AND adverse drug reactions/ adverse effects, re-
stricted to ‘all children’ and English language yielded 34, 95 
and 31 articles, respectively, of which 9, 17 and 8 were rele-
vant data papers, and 23, 64 and 19 were on unrelated topics. 
Repeating the searches on Embase identified a further 2 rele-
vant articles. When the Cochrane database was searched with 
the terms antibiotics AND allergy/ allergic disorders/ ec-
zema/ asthma, no relevant reviews were identified. Refer-
ence lists were searched for further studies. Most articles 
retrieved by these terms related to acute responses to antibi-
otic administration, indicating the relatively low profile of 
the adverse drug reaction under consideration. 
  Studies and methods employed were described (Tables 1 
and 2). All studies were observational: no experimental work 
was identified. There is no consensus as to appropriate qual-
ity indicators for adverse event research, as discussed below; 
therefore, we included all papers containing relevant data. 
The diversity of populations studied and methods employed 
precluded any statistical analyses. 
EXISTING STUDIES 
  The largest available dataset indicated that antibiotic ad-
ministration in the first year of life increased the risk of GP 
diagnosis of eczema before age 11. However, there were 
inconsistencies in the dose-response relationship: one course 
of antibiotics increased the risk of eczema (adjusted hazard 
ratio (aHR) 1.22 (95% CI 1.12-1.34), but four or more did 
not [37]. Also, this study did not account for antibiotic doses, 
home environment, family history and laboratory parame-
ters. Farooqi and Hopkin (1998) reported a similar associa-
tion with antibiotic use in the first 2 years of life [38]. Most 
retrospective studies have indicated an increased risk of 
childhood eczema if antibiotics are administered within the 
first 1-3 years of life [34, 38-43]. Others have found an asso-
ciation with antibiotics in pregnancy, but not in the first year 
of life [44], while another medical record study [45], a case-
control study with no figures [46] and a prospective cohort 
[47] found no association (Table 1). 
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Table 1.  Antibiotic Exposure and Risk of Eczema in Childhood 
 
Ref. Population   
Time of Antibi-
otic Prescrip-
tion(s) 
Method   Antibiotic Use 
Assessed by 
Number 
in Study 
Findings 
/ OR 
Linked to 
Eczema 
95% CI  Comments 
McKeever et al. 
2002 [27] 
Children in the 
English midlands, 
under 11 years 
1
st year of life 
Retrospective 
cohort.   GP records 
21,129, 
72.3% of 
available 
records 
(aHR) 1.22  Yes 1.12-1.34 
Inconsistent 
dose-response 
relationship. 
No data on 
confounding 
variables 
Von Mutius  
et al. 1999 [40] 
Dresden, children, 
aged 5-11 
1
st year 1-2 
courses 
Survey, clinical 
examination, 
venous bloods 
for IgE antibod-
ies 
Retrospective 
questionnaires to 
parents  
12 601  1.26  Yes  1.05-1.52   
Floistrup et al. 
2006 [34] 
Steiner school 
children and a 
comparator group, 
age 5-13 
1
st year  
Survey ques-
tionnaires to 
parents 
Blood samples 
for IgE estima-
tion 
Retrospective 
questionnaires to 
parents. 
6733   1.61  Yes  1.21-2.15   
Cohet et al. 2005 
[39] 
New Zealand chil-
dren age 6-7, 1584 
with previous 
notifiable infection 
plus a general 
population group  
1
st year 
Survey. 
Questionnaires 
mailed to par-
ents 
Retrospective 
questionnaires to 
parents. 
4123 1.40  Yes    1.21-1.62 
Eczema not 
linked to infec-
tions 
Kummeling  
et al. 2007 [47] 
Netherlands, chil-
dren up to 2 years 
1
st 6 months, 
including ad-
ministration to 
breastfeeding 
mothers 
Prospective 
cohort 
Retrospective 
questionnaires to 
parents. 
2764 0.94  No    0.75-1.18   
Faroogqi and 
Hopkin 1998 
[38] 
Children up to 12 
years in a family 
doctor practice in 
Oxfordshire, UK 
1
st 2 years 
Retrospective 
cohort using. GP 
& public health 
records 
GP records  1934  2.04  Yes   1.53-2.72 
Stronger asso-
ciation with 
broad spectrum 
antibiotic 
Droste et al. 
2000 [41] 
Belgium, children 
age 7-8 years  1
st year 
Survey ques-
tionnaires to 
parents. Skin 
prick tests 
Retrospective 
questionnaires to 
parents. 
1206 1.3 
95% CI 
includes 1, 
uncertain 
1.0-1.80   
Sariachvili et al. 
2007 [44] 
Belgium. Infants 
age 1 year  1
st year 
Prospective 
cohort. Parents’ 
reports of ec-
zema and IgE 
antibody meas-
urements 
Retrospective 
reports of moth-
ers at 3, 6 and 12 
months  
976 1.1  no    0.8-1.5   
Celedon et al. 
2002 [52] 
Boston USA, at age 
5 years  1
st year 
Prospective 
cohort. Parents’ 
reports of illness 
Telephone ques-
tionnaires to 
parents, every 2 
months for 2 
years 
498 1.1  no  0.4-3.1 
1 parent with a 
history of 
asthma or 
allergy. No 
association 
with allergic 
rhinitis 
Jedrychowski  
et al. 2006 [28]  Krakow, age 1 year  Pregnancy  
Prospective 
cohort 
Questionnaires 
to mothers every 
3 months  
102 2.30  No    0.91-5.80   
McKeever et al. 
2002 [37] 
Children in the 
English midlands, 
age 11 years 
Pregnancy  
Retrospective 
cohort 
Database of GP 
records  24 690   (aHR) 1.19  Yes   1.09-1.31 
Risk increases 
with more 
courses. Simi-
lar association 
with hayfever 
Sariachvili et al. 
2007 [44] 
Belgium. Infants 
age 1  Pregnancy  
Prospective 
cohort. Parents’ 
reports of ec-
zema 
Retrospective 
reports of moth-
ers at 5 months’ 
gestation & 3 
months of life 
976 1.8 Yes    1.2-2.7   
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  In the main, these are retrospective studies, relying on 
questionnaires administered to parents, asking for recall of 
administration of antibiotics up to 6 to 10 years previously. 
Information collected from participants is vulnerable to re-
call bias and, if collected more than 2 weeks after the event, 
forgetfulness [48], which concurs with our experience that 
many parents are unable to recall accurately the names, 
doses and usage of antibiotics over a 6 week period. Most 
retrospective questionnaire data collection in this area has 
used the ISAAC questionnaire. A retest of this questionnaire 
by 347 parents within 12 months gave a kappa value of 0.63 
(95%CI 0.57-0.69) for reports of antibiotic usage in the first 
3 years of life, indicating incomplete agreement between 
parents’ initial response and the re-test [40]. 
  More work has been done on asthma, and the findings are 
less equivocal (Table 2). A meta-analysis of 8 studies indi-
cated that use of any antibiotics in the first year of life was 
significantly associated with childhood asthma. The associa-
tion was stronger in retrospective than prospective cohorts 
(OR 2.82 (2.07-3.85) versus OR 1.12 (0.88-1.42)), highlight-
ing the need for further prospective work [49]. Also, the 
largest study suggested a dose/response relationship: antibi-
otic administration in the first year of life increased the risk 
of GP diagnosis of asthma before age 11, depending on the 
number of courses prescribed: HR 1.26 (1.13-1.40) for one 
course, and HR 1.99 (1.72-2.31) for four or more courses 
[37]. Most studies support these findings [34, 38-42, 50, 51]. 
However, the association is refuted by a body of research, 
mainly that relying on parental report of antibiotic use [52, 
53], but also two record reviews [45, 54], and a case-control 
study found an association for use in the first 3 years, but not 
the first year [55]. Although children living on farms in 
Eastern Europe are relatively immune from allergic disor-
ders, asthma is more common amongst children on farms in 
the American mid-West where antibiotics are added to ani-
mal feed [56]. 
  Some studies which linked antibiotics to asthma or ec-
zema found no association between antibiotics and atopy 
(assessed by skin prick tests or measurement of IgE antibod-
ies in venous blood) [34, 40, 41, 50, 51] (Table 3). 
  Allergic disorders and atopy tend to run in families, but 
only smaller studies have focused on families at high risk of 
allergic disorders (n=1460, 448, 937, total 2845) [39, 52, 
53], and the largest of these was retrospective. The impact of 
antibiotics may be limited to certain subgroups, for example, 
homes with <2 pets, infants breastfed >4months [57], or a 
family history of allergy (OR for eczema 1.6 95%CI 1.0-2.6) 
[41]. There are suggestions that type of antibiotic is impor-
tant, with broad-spectrum antibiotics having a stronger asso-
ciation [37, 38]. 
ANTIBIOTICS AND PROBIOTICS 
  The bacteria which colonise the sterile gastrointestinal 
tract of newborn infants include lactic acid producing bacte-
ria, enterobacteria, streptococci and staphylococci [58]. 
Where lactic acid producing bacteria are relatively deficient 
in the gut microflora, the neonatal immune system develops 
suboptimally, leaving the infant susceptible to allergic disor-
ders [59]. 
 
  Probiotic food supplements contain lactic acid producing 
bacteria and are known to affect the neonatal gut flora. It is 
suggested that this induces the maturation of Th1 cells, 
which inhibit the development of the signs and symptoms of 
allergy [60, 61]. The potential of prophylactic probiotics to 
prevent allergic disorders [60, 62] is supported by a meta-
analysis of 5 clinical trials with atopic dermatitis/ eczema as 
the primary outcome (relative risk 0.61 (0.49-0.74 in a fixed 
effects model, n=1406) [63]. Clinical trials of infant formula 
feeds containing probiotic organisms are underway [64, 65]. 
However, there are concerns that any benefits probiotics 
confer could be negated by antibiotics, which disrupt the gut 
flora [39, 66, 67]. 
EVIDENCE FOR ADVERSE EFFECTS 
  There is no single hierarchy of evidence or a single ‘gold 
standard’ research method for the identification of the ad-
verse effects of treatment [68]. Even the best-funded ran-
domised controlled trials are rarely powered to detect ad-
verse effects [69, 70], and the best-conducted trials may be 
confounded or obfuscated by cross-over [71]. 
  To date, ethical and practical considerations, not least the 
time between antibiotic administration and the onset of aller-
gic disorders, have precluded investigation of this adverse 
drug reaction by clinical trials. Causal relationships between 
medication and adverse events cannot always be formally 
tested by experimental research, and may retain an element 
of subjective interpretation [68, 72, 73]. Therefore, the dose-
response relationship remains pivotal in identifying adverse 
drug reactions [74] and establishing causality [19, 75]. Al-
though the putative association between antibiotics and al-
lergic disorders has been explored by a variety of non-
experimental methods (Tables 1-3), none of these studies 
have recorded doses prescribed or obtained detailed informa-
tion on the balance of the immune system and its cytokines, 
leaving some of the Bradford Hill [19] criteria unfulfilled. 
  Antibiotic administration is unlikely to be the only cause 
of allergic disorders. There are several possible explanations 
for the increased incidence in allergic disorders that co-
incided with the introduction of antibiotics: genetic predis-
position, infant feeding, urban living and other environ-
mental factors are likely to be involved. Associations uncov-
ered in non-experimental observational research do not allow 
attribution of causation: children vulnerable to allergic dis-
orders may also be in greater need of antibiotics, and chil-
dren with asthma are prescribed more antibiotics than their 
contemporaries [76]. Although children wheezing at age 8 
were prescribed more antibiotics, the association almost dis-
appeared when only antibiotics for non-respiratory infections 
were considered (OR 1.05 CI 1.00-1.10) [53]. In contrast, 
other work indicated that the association remained when 
antibiotics for lower respiratory tract infections are excluded 
[38]. 
  Asthma is associated with repeated upper respiratory tract 
infections in childhood [77]. While some studies indicate that 
children with atopy suffer more viral infections [38], the larg-
est UK cohort found no association between infections and 
allergic disorders [37], and low numbers of respiratory tract 
infections, allergies and antibiotic prescriptions characterise   
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Table 2.  Antibiotic Exposure and Risk of Asthma 
 
Ref.   Population  
Time of 
Antibiotic 
Prescription 
(s)  
Method  Antibiotic Use As-
sessed by 
Number  
in Study 
Findings 
/OR 
Antibiotics 
Associated 
with Asthma 
or Wheezing 
95% CI  Comments  
Marra et al. 
2006 [49] 
Studies pub-
lished in Eng-
lish 
1
st year, at 
least 1 course 
Meta-analysis, 4 
retrospective, plus 4 
prospective studies 
Not specified  27 167  2.05  yes  1.41-2.99 
Association 
stronger for 
retrospective 
studies 
Ahn et al. 
2005 [42] 
Korean chil-
dren, aged 7-
12 
1
st year of life  Retrospective survey  Retrospective 
questionnaires to 
parents 
26 400  1.86  Yes  1.67-2.08 
Similar asso-
ciation with 
wheeze in last 
12 months 
McKeever  
et al. 2002 [27] 
Children in the 
English mid-
lands, age 11 
years 
1
st year of life  Retrospective cohort.  Database of GP re-
cords  21 129  (aHR)  
1.99  yes 1.72-2.31   
Von Mutius  
et al. 1999 [40] 
Dresden, chil-
dren 5-11  1
st year  
Survey, clinical 
examination, venous 
bloods for IgE 
Retrospective ques-
tionnaire to parents.  12 601  1.64  yes  1.26-2.13   
Floistrup et al. 
2006 [34] 
European 
Steiner school 
children and a 
comparator 
group, age 5-
13 
1
st year  
Survey of parents 
IgE antibody 
measurements 
 
Retrospective 
questionnaires to 
parents. 
6733 2.79  Yes 2.03-3.83   
Celedon et al. 
2004 [45] 
Boston USA, 
children age 2-
5, >4 courses 
1
st year  Retrospective cohort 
Record review of 
automated medical 
record systems 
4408 0.9  no  0.6-1.3   
Cohet et al. 
2005 [39] 
New Zealand 
children age 6-
7, 1584 with 
previous noti-
fiable infection 
plus a general 
population 
group 
1
st year  Survey by mailed 
questionnaire 
Retrospective 
questionnaires to 
parents. 
4123 2.10  Yes 1.79-2.48 
Asthma not 
linked to 
notifiable 
infections 
Kummeling 
et al. 2007 [47] 
Netherlands. 
Children 
wheezing in 1
st 
2 years 
1
st 6 months, 
including 
administration 
to breastfeed-
ing mothers 
Prospective cohort  Retrospective 
questionnaires  2764 2.32  Yes 1.55-3.48   
Farooqi and 
Hopkin 1998 
[38] 
Children up to 
12 in a family 
doctor practice 
in Oxfordshire, 
UK 
1
st 2 years 
Retrospective cohort 
using. GP & public 
health records 
GP  records  1934 3.19  yes 2.43-4.18   
Droste et al. 
2000 [41] 
Belgium, chil-
dren aged 7-8  1
st year 
Survey question-
naires to parents. 
Skin prick tests 
Retrospective 
questionnaires to 
parents. 
1206 1.7 
Confidence 
interval in-
cludes 1 
1.0-3.1  
Illi et al. 2001 
[53] 
German chil-
dren aged 7 
years 
1
st 7 years 
Prospective cohort. 
Interviews of par-
ents, venous blood 
samples for IgE 
estimation, clinical 
examination 
Parental report of 
antibiotic use  1120 1.08  no 0.59-1.99 
Antibiotics 
for lower 
respiratory 
tract infec-
tions ex-
cluded  
Cullinan et al. 
2004 [50] 
Asthma in 
adults in Kent, 
UK 
1
st 5 years  
Retrospective cohort. 
self-report of illness 
as adult 
GP records of 
prescriptions   746 1.08  yes  1.03-1.13   Antibiotics and Allergic Disorders in Childhood  The Open Nursing Journal, 2008, Volume 2    53 
 
childhood in rural Poland [14]. The effect of antibiotics on 
allergic disorders is more marked for early exposure [37]. 
Crucial development of the immune system occurs in very 
early life [20]. Therefore, even large datasets without peripar-
tum data, such as GP records, may fail to identify associations. 
DISCUSSION 
  Allergic disorders remain a major public health problem, 
but their aetiology is largely unknown. Antibiotic prescribing 
has been extended to nurses and other health care profes-
sionals, devolving responsibilities from doctors to healthcare 
professionals who may have received a less detailed educa-
tion and preparation in pharmacology and immunology, or 
may be more vulnerable to pharmaceutical industry promo-
tions [78]. Antibiotics save lives and cure infections, but 
they can be over-prescribed [79, 80]. When prescribed for 
sore throat, ear or upper respiratory tract infections, antibiot-
ics reduce the risk of serious complications, but, in UK gen-
eral practice, over 4,000 patients need to be treated to pre-
vent one complication [81]. However, withholding therapy 
from severely ill patients may jeopardise the management of 
potentially serious or life-threatening infections [82, 83]. 
Delayed administration of antibiotics in patients with con-
firmed bacterial meningitis increases the risk of adverse out-
comes [84]. For every 100 courses of antibiotics prescribed 
to treat chest infections in children, one case of pneumonia is 
prevented [81]. There are concerns that therapeutic Calvin-
ism may be responsible for the rising incidence of rheumatic 
fever and renal damage secondary to streptococcal infections 
in children aged 4-15. Consequently, a more selective ap-
proach to antibiotic therapy for sore throats, using laboratory 
tests, is advocated [85]. This approach reduces antibiotic 
prescribing for children 3-17 with sore throats, but without 
reducing overall paediatric primary care antibiotic prescrib-
ing [18]. 
  If antibiotic administration is to be rationalised, profes-
sionals and patients need full information of their risks and 
benefits or harms. Most antibiotic prescribing takes place in 
primary care, where there is considerable variation between 
practitioners [86]. Interventions to reduce antibiotic prescrib-
ing have been successful [87], which might indicate that 
scope for practice modification exists. Current guidelines 
and quality indicators for antibiotic prescribing focus on bac-
terial resistance, and offer no consensus [88, 89], reflecting 
tensions between the needs of individual patients and public 
health priorities [90]. However, due to the paucity of evi-
dence, current guidelines take little account of allergic disor-
ders. Those developing prescribing guidelines should not 
(Table 2) contd….. 
Ref.   Population  
Time of 
Antibiotic 
Prescription 
(s)  
Method  Antibiotic Use As-
sessed by 
Number  
in Study 
Findings 
/OR 
Antibiotics 
Associated 
with Asthma 
or Wheezing 
95% CI  Comments  
Harris et al. 
2007 [54] 
Children aged 
8, in Kent, UK  1
st 5 years 
Prospective cohort. 
Annual retrospective 
questionnaires to 
parents 
GP records  523  1.07  yes  1.03-1.10 
Current 
wheezing as 
end point. 
Association 
reduces 
when respi-
ratory infec-
tions are 
discounted 
Celedon et al. 
2002 [52] 
Boston USA, 
children age 5  1
st year 
Prospective cohort. 
Parents’ reports of 
illness 
Retrospective ques-
tionnaires by tele-
phone to parents, 
every 2 months for 2 
years 
498 0.9  no  0.4-1.8   
Wickens et al. 
1999 [51] 
Children in 
Steiner schools 
in New Zea-
land  
1
st year  Survey of parents  Retrospective 
questionnaires to 
parents 
456   2.74  yes  1.110-6.85   
Thomas et al. 
2006 [55] 
Manchester, 
UK, children 
aged 3-5 
1
st year  Case control.  
Medical records and 
prospective parental 
diaries 
72 1.32  no 0.99-1.78 
Association 
found if first 
3 years’ use 
was consid-
ered 
McKeever  
et al. 2002 [37] 
Children in the 
English mid-
lands, under 11 
years 
During preg-
nancy >2 
courses 
Retrospective co-
hort.  
Database of GP re-
cords  24 690   (aHR) 
1.12  yes 1.02-1.24 
Risk not 
significant 
with fewer 
courses.  
Jedrychowski 
et al. 2006 [28] 
Krakow chil-
dren age 1 
year, non-
smoking 
mothers 
During 2
nd & 
3
rd trimesters 
of pregnancy  
Prospective cohort 
Retrospective 
questionnaires to 
mothers every 3 
months 
102 4.42  yes 1.05-18.8 
Similar 
association 
with allergic 
rhinitis 
Papers are ordered by sample size. 54    The Open Nursing Journal, 2008, Volume 2  Jordan et al. 
regard absence of evidence as equivalent to evidence of ab-
sence when considering the risk of adverse drug reactions. 
  Allergic disorders in childhood disproportionately afflict 
children from disadvantaged backgrounds [87], particularly 
the urban poor of the USA. The high incidence of allergic 
disorders amongst children of large families, living in over-
crowded and rat or cockroach-infested homes reduces the 
plausibility of the ‘hygiene hypothesis’ [91]. Poorer pre-
school children are more likely to be prescribed antibiotics in 
primary care for viral infections [92], and at an earlier age 
[93]. Therefore, children from disadvantaged backgrounds 
will benefit most from modifications in GP prescribing. 
  The public health importance of this putative association 
indicates that this issue requires further exploration. It is im-
portant to capture and disseminate the impact of prescribing 
while the data is relatively contemporary. Previous studies 
are based on the prescribing patterns of the 1980s [38, 40, 
41, 50, 56] or earlier [49]. Changes in GP prescribing of an-
tibiotics 1995-2000 [17] and epidemiological trends [15, 16] 
indicate that previous work may be obsolescent. 
IMPLICATIONS 
  When caring for children who have received numerous 
courses of antibiotics and whose mothers received antibiotics 
in pregnancy, practitioners should be alert for the signs and 
symptoms of eczema and asthma and consider prompt refer-
ral. 
  Professionals, including nurses, making prescribing deci-
sions, or planning follow-up patient monitoring and surveil-
lance [94], need evidence on both the benefits and harms of 
medications. Evidence-based medicine is only valuable to 
the extent that the evidence base is complete [95]. Without 
prospective studies, the temporal link between respiratory 
tract infections, administration of antibiotics and allergic 
Table 3.  Antibiotic Exposure and Risk of Atopy 
 
Ref. Population   
Time of Anti-
biotic Pre-
scription (s) 
Method  Antibiotic Use 
Assessed by: 
Number 
in Study 
Findings/ 
OR 
Antibiotics 
Associated 
with Atopy 
95% CI  Comments  
Von Mutius et 
al. 1999 [40] 
Dresden, children 
aged 5-11 
1
st year >5 
courses 
Survey. Ques-
tionnaires to 
parents, clinical 
examination, 
venous bloods 
for IgE 
Antibiotic use 
assessed by retro-
spective ques-
tionnaires 
5067 0.92  no 0.72-1.17   
Tamay et al. 
2007 [43] 
Istanbul, children 
aged 6-12  1
st year  Survey  
Retrospective 
questionnaires to 
parents 
2387, 
95% 
response 
rate 
1.26 yes  1.01-1.57 
Outcome was 
allergic rhinitis, 
used as marker 
for atopy 
Floistrup et al. 
2006 [34] 
Steiner school 
children and a 
comparator group, 
age 5-13 
1
st year  
Survey of par-
ents. Blood 
samples for IgE 
estimation 
Antibiotic use 
assessed by retro-
spective ques-
tionnaires 
1856 1.15  no 0.84-1.58   
Kummeling et 
al. 2007 [47] 
Netherlands. Chil-
dren up to 2 years 
1
st 6 months, 
including 
administration 
to breastfeed-
ing mothers 
Prospective 
cohort 
Antibiotic use 
assessed by retro-
spective ques-
tionnaires 
815 1.32  No 0.86-2.02   
Cullinan et al. 
2004 [50] 
Atopy (positive 
skin prick test) in 
adults in Kent 
1
st 5 years 
Retrospective 
cohort, 
self-report of 
illness 
GP records of 
prescriptions   746 OR  1.01  no 0.97-1.05 
No association 
with hayfever, 
but association 
with asthma, 
above 
Droste et al. 
2000 [41] 
Belgium, children 
aged 7-8  1
st year 
Survey ques-
tionnaires to 
parents. Skin 
prick tests 
Retrospective 
questionnaires to 
parents. 
675 OR  1.1  no  0.7-1.7    
Harris et al. 
2007 [54] 
Children aged 8, in 
Kent, UK  1
st 5 years 
Prospective 
cohort. Annual 
retrospective 
questionnaires to 
parents 
GP records  490  1.00  no  0.97-1.03  Atopy assessed 
from notes 
Johnson et al. 
2005 [57] 
Detroit, USA, 
children aged 6-7 
1
st 6 months 
Prospective 
cohort Clinical 
examination, 
skin prick tests, 
IgE from venous 
blood 
All Medical 
records. 
488 1.48  no 0.94-2.34  associations in 
subgroups 
Papers are ordered by sample size. 
aHR, adjusted hazard ratio; OR, odds ration; CI, confidence intervals; GP, general (medical) practitioner. Antibiotics and Allergic Disorders in Childhood  The Open Nursing Journal, 2008, Volume 2    55 
disorders and the appearance in the defect in Th1 maturation 
associated with allergic disorders [96] will remain unknown. 
If research funding, and research effort, is disproportionately 
devoted to assessing the benefits of prescribed medications, 
the evidence presented to practitioners may not be a true or 
valid reflection of reality. 
  Safe prescribing, and the prevention of adverse drug re-
actions, form an important part of the policy agenda [97, 98]. 
The importance of local and national guidelines in directing 
practice should not be underestimated [90, 99]. However, 
without further funding, prescribing guidelines will be un-
able to take account of the possibility that, when other risk 
factors are accounted for, there is both a dose-response rela-
tionship and a biologically plausible association between 
antibiotics prescribed and the incidence of allergic disorders 
in children. 
GLOSSARY 
•  Antibodies. : Immunoglobulin proteins secreted by B 
lymphocytes. Antibody synthesis is induced by spe-
cific antigens, and they combine with these specific 
antigens usually to initiate pathogenic destruction. An 
antigen is any molecule, usually a protein or polysac-
charide, that interact with an antibody. The term anti-
gen is usually used in immunology to describe foreign 
material although antigens can be generated within 
the body e.g. A and B antigens on the surface of 
erythrocytes. 
•  Atopy. A genetic predisposition to immediate allergic 
response to common environmental antigens, such as 
pollen, house mites. Clinical manifestations include 
hayfever, asthma (some types), eczema or atopic 
dermatitis, food and drug allergies. 
•  Cytokines.  Proteins released from cells of the im-
mune system to communicate with and regulate other 
cells of the immune system. 
•  Histamine. This is released by basophils, mast cells 
and platelets. It causes local vascular dilation, an im-
mediate increase in vascular permeability, swelling 
and itching. It is released on contact with stinging net-
tles and in some allergies. The problems caused by 
histamine are ameliorated by antihistamine creams or 
tablets. 
•  Th or helper T cells. Lymphocytes which direct 
other lymphocytes by releasing cytokines. The 2 main 
types are Th1 and Th2. 
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